Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
15.12.25
/
50%
€170.00
Target price
15.12.26
€219.76
Performance (%)
-21.18%
Price
30.03.26
?
Summary
This prediction is currently active. The price of Insmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -21.18%. This prediction currently runs until 15.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -1.538% | -1.538% |
| iShares Core DAX® | -0.479% | -12.062% |
| iShares Nasdaq 100 | -3.377% | -5.130% |
| iShares Nikkei 225® | -0.143% | -12.633% |
| iShares S&P 500 | -2.266% | -5.049% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $225.00 to $258.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat